Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Bonnefois

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2025
Beyond the linear model in concentration-QT analysisGéraldine Cellière, Andreas Krause, Guillaume Bonnefois, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2021
Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimatesMario González-Sales, Nick Holford, Guillaume Bonnefois, et al.
Clinical and Translational Science|February 16, 2022
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulationsAbdullah Aljutayli, Daniel J G Thirion, Guillaume Bonnefois, et al.
Journal of Child and Adolescent Psychopharmacology|February 5, 2019
A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentSara Soufsaf, Philippe Robaey, Guillaume Bonnefois, et al.
Journal of Child and Adolescent Psychopharmacology|February 7, 2017
An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentGuillaume Bonnefois, Philippe Robaey, Olivier Barrière, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2021
Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submissionMario González-Sales, Nassim Djebli, Georgina Meneses-Lorente, et al.
Clinical and Translational Science|July 24, 2020
Population Pharmacokinetics of Candesartan in Patients with Chronic Heart FailureImad Kassem, Steven Sanche, Jun Li, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2025
Beyond the linear model in concentration-QT analysisGéraldine Cellière, Andreas Krause, Guillaume Bonnefois, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2021
Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimatesMario González-Sales, Nick Holford, Guillaume Bonnefois, et al.
Clinical and Translational Science|February 16, 2022
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulationsAbdullah Aljutayli, Daniel J G Thirion, Guillaume Bonnefois, et al.
Journal of Child and Adolescent Psychopharmacology|February 5, 2019
A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentSara Soufsaf, Philippe Robaey, Guillaume Bonnefois, et al.
Journal of Child and Adolescent Psychopharmacology|February 7, 2017
An Evaluation Approach for the Performance of Dosing Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentGuillaume Bonnefois, Philippe Robaey, Olivier Barrière, et al.
Cancer Chemotherapy and Pharmacology|September 18, 2021
Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submissionMario González-Sales, Nassim Djebli, Georgina Meneses-Lorente, et al.
Clinical and Translational Science|July 24, 2020
Population Pharmacokinetics of Candesartan in Patients with Chronic Heart FailureImad Kassem, Steven Sanche, Jun Li, et al.
Pageof 1